Empirical support for an involvement of the mesostriatal dopamine system in human fear extinction

Translational Psychiatry

Volumn 1, Issue , 2011, Pages

  Raczka, K A ^a   Mechias, M L ^a   Gartmann, N ^a   Reif, A ^b   Deckert, J ^b   Pessiglione, M ^c   Kalisch, R ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

Author keywords

Conditioning; DAT1; dopamine transporter; prediction error; safety learning; ventral striatum

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE; DOPAMINE TRANSPORTER;

ADULT; ARTICLE; BASAL GANGLION; CONDITIONED REFLEX; FEAR; GENETICS; HUMAN; MALE; METABOLISM; METHODOLOGY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; REINFORCEMENT;

ADULT; BASAL GANGLIA; CATECHOL O-METHYLTRANSFERASE; CONDITIONING, CLASSICAL; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; EXTINCTION, PSYCHOLOGICAL; FEAR; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS;

EID: 79959573243     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2011.10     Document Type: Article

References (56)

1. Rescorla RA, Wagner AR. A theory of Pavlovian conditioning: variations in the effectiveness of reinforcement and nonreinforcement. In: Rescorla RA, Wagner AR, Black AH, Prokasy WF (eds). Classical Conditioning II: Current Research and Theory. Appleton-Century-Crofts: New York, NY, 1972, pp 64-99.
2. Sutton RS, Barto AG. Reinforcement Learning: an Introduction (Adaptive Computation andMachine Learning). MIT Press: Cambridge, Massachusetts, 1998.
3. Rothbaum BO, Davis M. Applying learning principles to the treatment of post-trauma reactions. Ann N YAcad Sci 2003; 1008:112-121. (Pubitemid 38265155)
4. Pavlov IP. Conditioned reflexes: an investigation of the physiological activity of the cerebralcortex. Oxford University Press: Oxford, 1927.
5. Myers KM, Davis M. Behavioral and neural analysis of extinction. Neuron 2002; 36: 567-584. (Pubitemid 35346753)
6. Bouton ME. Context and behavioral processes in extinction. Learn Mem 2004; 11: 485-494. (Pubitemid 39299694)
7. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature 2002; 418: 530-534. (Pubitemid 34851398)
8. Lin CH, Yeh SH, Lu HY, Gean PW. The similarities and diversities of signal pathways leading to consolidation of conditioning and consolidation of extinction of fear memory. J Neurosci 2003; 23: 8310-8317.
9. Gottfried JA, Dolan RJ. Human orbitofrontal cortex mediates extinction learning while accessing conditioned representations ofvalue. Nat Neurosci 2004; 7:1144-1152. (Pubitemid 41184456)
10. Heldt SA, Stanek L, Chhatwal JP, Ressler KJ. Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Mol Psychiatry 2007; 12: 656-670. (Pubitemid 46998249)
11. Herry C, Ciocchi S, Senn V, Demmou L, Muller C, Luthi A. Switching on and off fear by distinct neuronal circuits. Nature 2008; 454: 600-606.
12. Jungling K, Seidenbecher T, Sosulina L, Lesting J, Sangha S, Clark SD et al. Neuropeptide S-mediated control of fear expression and extinction: role of intercalated GABAergic neurons in the amygdala. Neuron 2008; 59: 298-310. (Pubitemid 352033690)
13. Montague PR, Hyman SE, Cohen JD. Computational roles for dopamine in behavioural control. Nature 2004; 431:760-767. (Pubitemid 39434064)
14. Pessiglione M, Seymour B, Flandin G, Dolan RJ, Frith CD. Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature 2006; 442: 1042-1045. (Pubitemid 44330261)
15. Schultz W. Behavioral theories and the neurophysiology of reward. Ann RevPsychol 2006; 57: 87-115. (Pubitemid 43237228)
16. Holtzman-Assif O, Laurent V, Westbrook RF. Blockade of dopamine activity in the nucleus accumbens impairs learning extinction of conditioned fear. Learn Mem 2010; 17: 71-75.
17. El Ghundi M, O'Dowd BF, George SR. Prolonged fear responses in mice lacking dopamine D1 receptor. Brain Res 2001; 892: 86-93. (Pubitemid 32126570)
18. Cragg SJ, Rice ME. DAncing past the DAT at a DA synapse. Trends Neurosci 2004; 27: 270-277. (Pubitemid 38529955)
19. Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW et al. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 1992; 14:1104-1106. (Pubitemid 23053054)
20. Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG et al. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 2000; 22:133-139. (Pubitemid 30016015)
21. Jacobsen LK, Staley JK, Zoghbi SS, Seibyl JP, Kosten TR, Innis RB et al. Prediction of dopamine transporter binding availability by genotype: a preliminary report. Am J Psychiatry 2000; 157:1700-1703.
22. Fuke S, Suo S,Takahashi N, Koike H, Sasagawa N, Ishiura S. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J 2001; 1:152-156. (Pubitemid 33757602)
23. Mill J, Asherson P, Browes C, D'Souza U, Craig I. Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR. Am J Med Genet 2002; 114: 975-979. (Pubitemid 35379243)
24. VanNess SH, Owens MJ, Kilts CD. The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density. BMC Genet 2005; 6: 55.
25. van Dyck CH, Malison RT, Jacobsen LK, Seibyl JP, Staley JK, Laruelle M et al. Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene. J Nucl Med 2005; 46: 745-751.
26. Matsumoto M, Weickert CS, Akil M, Lipska BK, Hyde TM, Herman MM et al. Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronalfunction. Neurosci 2003; 116:127-137. (Pubitemid 36110440)
27. Tunbridge EM, Harrison PJ, Weinberger DR. Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol Psychiatry 2006; 60:141-151.
28. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996; 6: 243-250. (Pubitemid 26226317)
29. ChenJ, Lipska BK, Halim N, MaQD, Matsumoto M, Melhem S et al. Functional analysisof genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 2004; 75: 807-821. (Pubitemid 39390488)
30. Morrow BA, Elsworth JD, Rasmusson AM, Roth RH. The role of mesoprefrontal dopamine neurons in the acquisition and expression of conditioned fear in the rat. Neurosci 1999; 92: 553-564. (Pubitemid 29268043)
31. Lonsdorf TB, Weike AI, Nikamo P, Schalling M, Hamm AO, Ohman A. Genetic gating of human fear learning and extinction: possible implications for gene-environment interaction in anxiety disorder. Psychol Sci 2009; 20:198-206.
32. Raczka KA, Gartmann N, Mechias ML, Reif A, Buchel C, Deckert J et al. Aneuropeptide S receptor variant associated with overinterpretation of fear reactions: a potential neurogeneticbasisforcatastrophizing. Mol Psychiatry 2010; 15:1045,1067-1074.
33. McClure SM, Berns GS, Montague PR. Temporal prediction errors in a passive learning task activate human striatum. Neuron 2003; 38: 339-346. (Pubitemid 36555658)
34. O'Doherty JP, Dayan P, Friston K, Critchley H, Dolan RJ. Temporal difference models and reward-related learning in the human brain. Neuron 2003; 38: 329-337. (Pubitemid 36555657)
35. Seymour B, O'Doherty JP, Dayan P, Koltzenburg M, Jones AK, Dolan RJ et al. Temporal difference models describe higher-order learning in humans. Nature 2004; 429: 664-667. (Pubitemid 38812318)
36. Menon M, Jensen J, Vitcu I, Graff-Guerrero A, Crawley A, Smith MA et al. Temporal difference modeling of the blood-oxygen level dependent response during aversive conditioning in humans: effects of dopaminergic modulation. Biol Psychiatry 2007; 62: 765-772. (Pubitemid 47381433)
37. Seymour B, Daw N, Dayan P, SingerT, Dolan R. Differential encoding of losses and gains in the human striatum. J Neurosci 2007; 27: 4826-4831. (Pubitemid 46699059)
38. Petrovic P, Kalisch R, Pessiglione M, Singer T, Dolan RJ. Learning affective values for faces is expressed in amygdala and fusiform gyrus. Soc Cogn Affect Neurosci 2008; 3: 109-118. (Pubitemid 351827054)
39. Schiller D, Levy I, Niv Y, LeDoux JE, Phelps EA. From fear to safety and back: reversal of fear in the human brain. J Neurosci 2008; 28:11517-11525.
40. Dayan P. Classical conditioning and reinforcement learning. In: Dayan P, Abbott LF (eds). Theoretical Neuroscience. MIT Press: Cambridge, MA, 2001, pp 331.
41. Friston KJ, Ashburner JT, Kiebel SJ, Nichols TE, Penny WD. Statistical Parametric Mapping: the Analysis of Functional Brain Images.Academic Press: San Diego, CA, 2007.
42. O'Doherty JP. Reward representations and reward-related learning in the human brain: insightsfrom neuroimaging. Curr Opin Neurobiol 2004; 14: 769-776. (Pubitemid 39576211)
43. Spoormaker VI, Andrade KC, Schroter MS, Sturm A, Goya-Maldonado R, Samann PG et al. The neural correlates of negative prediction error signaling in human fear conditioning. Neuroimage 2011; 54: 2250-2256.
44. Bilder RM, Volavka J, Lachman HM, Grace AA. The catechol-O- methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 2004; 29:1943-1961. (Pubitemid 39486546)
45. Meyer-Lindenberg A, Weinberger DR. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 2006; 7: 818-827. (Pubitemid 44435264)
46. Yacubian J, Sommer T, Schroeder K, Glascher J, Kalisch R, Leuenberger B et al. Gene-gene interaction associated with neural reward sensitivity. Proc Natl AcadSci USA 2007; 104: 8125-8130. (Pubitemid 47185886)
47. Solomon RL, Corbit JD. An opponent-process theory of motivation. I. Temporal dynamics of affect. Psychol Rev 1974; 81:119-145.
48. Dickinson A, Pearce JM. Inhibitory interactions between appetitive and aversive stimuli. Psychol Bull 1977;84: 690-711.
49. Mueller D, Bravo-Rivera C, Quirk GJ. Infralimbic D2 receptors are necessary for fear extinction and extinction-relatedtone responses. Biol Psychiatry 2010; 68:1055-1060.
50. Ponnusamy R, Nissim HA, Barad M. Systemic blockade of D2-like dopamine receptors facilitates extinction of conditioned fear in mice. Learn Mem 2005; 12: 399-406. (Pubitemid 41126853)
51. Hikind N, Maroun M. Microinfusion of the D1 receptorantagonist, SCH23390 into the IL but not the BLA impairs consolidation of extinction of auditory fear conditioning. Neurobiol Learn Mem 2008; 90: 217-222.
52. Milad MR, Goldstein JM, Orr SP, Wedig MM, Klibanski A, Pitman RK et al. Fear conditioning and extinction: influence of sex and menstrual cycle in healthy humans. Behav Neurosci 2006; 120:1196-1203. (Pubitemid 46058692)
53. Ressler KJ, Rothbaum BO, Tannenbaum L, Anderson P, Graap K, Zimand E et al. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry 2004; 61:1136-1144. (Pubitemid 39463415)
54. Grillon C. D-cycloserine facilitation of fear extinction and exposure-based therapy might rely on lower-level, automatic mechanisms. Biol Psychiatry 2009; 66: 636-641.
55. McNally GP, Westbrook RF. Opioid receptors regulate the extinction of Pavlovian fear conditioning. Behav Neurosci 2003; 117:1292-1301. (Pubitemid 37549430)
56. McNally GP, Pigg M, Weidemann G. Opioid receptors in the midbrain periaqueductal gray regulate extinction of pavlovian fear conditioning. J Neurosci 2004; 24: 6912-6919. (Pubitemid 39045448)